← Back to Search

Device

BAROSTIM NEO System for High Blood Pressure

N/A

Waitlist Available

Led By Hermann Haller, MD

Research Sponsored by CVRx, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for the duration of the study, up to 10 years.

Awards & highlights

Study Summary

This trial is looking at the long-term safety and effectiveness of a device called the BAROSTIM NEO System.

Who is the study for?

This trial is for people with high blood pressure that doesn't get better with medication. Participants must already be part of the Neo Non-Randomized Hypertension Study and have agreed to keep participating by signing a consent form. If their doctor thinks they shouldn't continue, they can't join.Check my eligibility

What is being tested?

The study is looking at how safe and effective the BAROSTIM NEO System is over a long time in patients who are already using it from an earlier study (NCT01471834). It compares regular medical management of high blood pressure with this system.See study design

What are the potential side effects?

While specific side effects aren't listed here, generally, device-related treatments like BAROSTIM NEO may cause discomfort at the implant site, infection risk, or nerve damage. Medical management side effects depend on the drugs used.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for the duration of the study, up to 10 years.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for the duration of the study, up to 10 years.

This trial's timeline: 3 weeks for screening, Varies for treatment, and for the duration of the study, up to 10 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To access long-term adverse events in participants implanted with the BAROSTIM NEO System.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Device and Medical ManagementExperimental Treatment2 Interventions

Participants will be implanted with the BAROSTIM NEO System and will continue to receive optimal, stable, Guideline Directed Medical Therapy (GDMT) for heart failure (American Heart Association [AHA] / American College of Cardiology [ACC] guidelines), including drugs to be determined by the subject's physician. Drug types include: Loop Diuretics, Thiazide Diuretics, Potassium-sparing Diuretics, Sequential Nephron Blockade, ACE Inhibitors, ARBs, ARNI, Aldosterone Antagonists, Beta Blockers and Hydralazine and Isosorbide Dinitrate.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Medical Management

2013

Completed Phase 4

~3060

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CVRx, Inc.Lead Sponsor

20 Previous Clinical Trials

8,798 Total Patients Enrolled

Hermann Haller, MDPrincipal InvestigatorHannover Medical School

Media Library

BAROSTIM NEO System (Device) Clinical Trial Eligibility Overview. Trial Name: NCT01471834 — N/A

High Blood Pressure Research Study Groups: Device and Medical Management

High Blood Pressure Clinical Trial 2023: BAROSTIM NEO System Highlights & Side Effects. Trial Name: NCT01471834 — N/A

BAROSTIM NEO System (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01471834 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to join the experiment?

"This research project is open to 40 hypertensive individuals aged between 21 and 80. To be eligible, they must already have been taking part in the Neo Non-Randomized Hypertension Study."

Answered by AI

Are there any available spots for individuals who wish to participate in this clinical research?

"The publicly available data on clinicaltrials.gov confirms that, at present, no more patients are needed for this particular medical trial which began in June 2011 and was last updated November 2021. Fortunately there are a multitude of other studies actively recruiting participants."

Answered by AI

Does this research permit octogenarians to participate?

"The trial's official entry requirements state that eligible participants must be between 21 and 80 years old. Separately, 54 clinical trials are open to minors while 662 studies are available for seniors over 65."

Answered by AI